Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics società ha sostenuto
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions leggi di più
My experience within my department has been fantastic. Cross functional interactions have often been good. Experiences with the prior executive team make-up were, at times, excruciating. I have great hope for the executive new team, however.
Che cosa ti rende più felice sul posto di lavoro?
Being able to get things done for patients
La cosa più positiva della cultura e l'ambiente presso la tua azienda?
It is stabilizing after years of being completely untenable. If I were based in the office, it is likely I would have moved on long ago.
Qual è la parte migliore del tuo compenso?
Great $ matching. Healthcare is excellent although difficult to manage in NYS. Wishing that there were more options based on field distribution (at same level of quality).
Quali sono alcune delle cose migliori della tuo team?
My team in particular has been incredibly stable for the last 5 years which is totally a result of the quality of our department head and in the people that we have hired. They have become family, not just coworkers and we all collaborate REALLY well.
Cosa ti piace di più del team di leadership?
The leadership team has become more stable over the last year. They seem to be realigning corporate strategy to that of a commercial entity rather than a start-up. The company culture has also become more stable and you can actually feel a collective sigh of relief.
Other Employee Reviews for Karyopharm Therapeutics
×